278 related articles for article (PubMed ID: 21424858)
1. A chemical biology approach to myocardial regeneration.
Willems E; Lanier M; Forte E; Lo F; Cashman J; Mercola M
J Cardiovasc Transl Res; 2011 Jun; 4(3):340-50. PubMed ID: 21424858
[TBL] [Abstract][Full Text] [Related]
2. Stimulating Cardiogenesis as a Treatment for Heart Failure.
Heallen TR; Kadow ZA; Kim JH; Wang J; Martin JF
Circ Res; 2019 May; 124(11):1647-1657. PubMed ID: 31120819
[TBL] [Abstract][Full Text] [Related]
3. Embryonic template-based generation and purification of pluripotent stem cell-derived cardiomyocytes for heart repair.
Dierickx P; Doevendans PA; Geijsen N; van Laake LW
J Cardiovasc Transl Res; 2012 Oct; 5(5):566-80. PubMed ID: 22806916
[TBL] [Abstract][Full Text] [Related]
4. Embryonic stem cells for severe heart failure: why and how?
Menasché P
J Cardiovasc Transl Res; 2012 Oct; 5(5):555-65. PubMed ID: 22411322
[TBL] [Abstract][Full Text] [Related]
5. Maturation status of sarcomere structure and function in human iPSC-derived cardiac myocytes.
Bedada FB; Wheelwright M; Metzger JM
Biochim Biophys Acta; 2016 Jul; 1863(7 Pt B):1829-38. PubMed ID: 26578113
[TBL] [Abstract][Full Text] [Related]
6. Stem cells as therapy for heart disease: iPSCs, ESCs, CSCs, and skeletal myoblasts.
Rikhtegar R; Pezeshkian M; Dolati S; Safaie N; Afrasiabi Rad A; Mahdipour M; Nouri M; Jodati AR; Yousefi M
Biomed Pharmacother; 2019 Jan; 109():304-313. PubMed ID: 30396088
[TBL] [Abstract][Full Text] [Related]
7. Efficient Cardiac Differentiation of Human Amniotic Fluid-Derived Stem Cells into Induced Pluripotent Stem Cells and Their Potential Immune Privilege.
Fang YH; Wang SPH; Gao ZH; Wu SN; Chang HY; Yang PJ; Liu PY; Liu YW
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235313
[TBL] [Abstract][Full Text] [Related]
8. Regenerative Medicine/Cardiac Cell Therapy: Pluripotent Stem Cells.
Duran AG; Reidell O; Stachelscheid H; Klose K; Gossen M; Falk V; Röll W; Stamm C
Thorac Cardiovasc Surg; 2018 Jan; 66(1):53-62. PubMed ID: 29216651
[TBL] [Abstract][Full Text] [Related]
9. Induced Pluripotent Stem Cells (iPSCs)-Roles in Regenerative Therapies, Disease Modelling and Drug Screening.
Aboul-Soud MAM; Alzahrani AJ; Mahmoud A
Cells; 2021 Sep; 10(9):. PubMed ID: 34571968
[TBL] [Abstract][Full Text] [Related]
10. Phospholamban as a crucial determinant of the inotropic response of human pluripotent stem cell-derived ventricular cardiomyocytes and engineered 3-dimensional tissue constructs.
Chen G; Li S; Karakikes I; Ren L; Chow MZ; Chopra A; Keung W; Yan B; Chan CW; Costa KD; Kong CW; Hajjar RJ; Chen CS; Li RA
Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):193-202. PubMed ID: 25504561
[TBL] [Abstract][Full Text] [Related]
11. Cardiac cell therapies: the next generation.
Choi YH; Saric T; Nasseri B; Hühn S; Van Linthout S; Hetzer R; Tschöpe C; Stamm C
Cardiovasc Ther; 2011 Feb; 29(1):2-16. PubMed ID: 20946322
[TBL] [Abstract][Full Text] [Related]
12. Stem Cell Technology in Cardiac Regeneration: A Pluripotent Stem Cell Promise.
Duelen R; Sampaolesi M
EBioMedicine; 2017 Feb; 16():30-40. PubMed ID: 28169191
[TBL] [Abstract][Full Text] [Related]
13. Paracrine Effects of the Pluripotent Stem Cell-Derived Cardiac Myocytes Salvage the Injured Myocardium.
Tachibana A; Santoso MR; Mahmoudi M; Shukla P; Wang L; Bennett M; Goldstone AB; Wang M; Fukushi M; Ebert AD; Woo YJ; Rulifson E; Yang PC
Circ Res; 2017 Sep; 121(6):e22-e36. PubMed ID: 28743804
[TBL] [Abstract][Full Text] [Related]
14. Induced pluripotent stem cells: developmental biology to regenerative medicine.
Nelson TJ; Martinez-Fernandez A; Terzic A
Nat Rev Cardiol; 2010 Dec; 7(12):700-10. PubMed ID: 20956984
[TBL] [Abstract][Full Text] [Related]
15. Human embryonic stem cells vs human induced pluripotent stem cells for cardiac repair.
Barad L; Schick R; Zeevi-Levin N; Itskovitz-Eldor J; Binah O
Can J Cardiol; 2014 Nov; 30(11):1279-87. PubMed ID: 25442431
[TBL] [Abstract][Full Text] [Related]
16. 'Shovel-Ready' applications of stem cell advances for pediatric heart disease.
Files MD; Boucek RJ
Curr Opin Pediatr; 2012 Oct; 24(5):577-83. PubMed ID: 22935754
[TBL] [Abstract][Full Text] [Related]
17. Short-term immunosuppression promotes engraftment of embryonic and induced pluripotent stem cells.
Pearl JI; Lee AS; Leveson-Gower DB; Sun N; Ghosh Z; Lan F; Ransohoff J; Negrin RS; Davis MM; Wu JC
Cell Stem Cell; 2011 Mar; 8(3):309-17. PubMed ID: 21362570
[TBL] [Abstract][Full Text] [Related]
18. iPS cells: a source of cardiac regeneration.
Yoshida Y; Yamanaka S
J Mol Cell Cardiol; 2011 Feb; 50(2):327-32. PubMed ID: 21040726
[TBL] [Abstract][Full Text] [Related]
19. Natural and synthetic regulators of embryonic stem cell cardiogenesis.
Willems E; Bushway PJ; Mercola M
Pediatr Cardiol; 2009 Jul; 30(5):635-42. PubMed ID: 19319460
[TBL] [Abstract][Full Text] [Related]
20. Peptidomimetic small-molecule compounds promoting cardiogenesis of stem cells.
Oh SW; Lee JB; Kim B; Jeon S; Kim MK; Nam KH; Ha JR; Bhatia M; Oh GT; Kim DY
Arch Pharm Res; 2012 Nov; 35(11):1979-88. PubMed ID: 23212640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
